Evidence map›Paper›PMID 37954524›Full record

ArticleInnovation in aging2023

Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model.

Boran Sun, Shatao Li, Yanbo Wang, Wenbo Xiao, Han Zhao, Xuewei Liu, Yang Liu, Xinlin Lu, Bei Gao, Jiangtao Zhou and 4 more

Open access · goldAbstract read
In one paragraph

Article in Innovation in aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Boran SunDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Shatao LiDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Yanbo WangDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Wenbo XiaoDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Han ZhaoDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Xuewei LiuDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Yang LiuDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Xinlin LuDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Bei GaoDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Jiangtao ZhouDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Bingyi WangDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Yuan WangDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Yongjie ChenDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.ORCID https://orcid.org/0000-0002-2559-498X
Wenli LuDepartment of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
Tianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Little is known about the sarcopenia transition process across different stages among Chinese community-dwelling older adults. We aimed to explore dynamic transitions of sarcopenia and its influencing factors in Chinese older adults. Research Design and Methods: Data were derived from the China Health and Retirement Longitudinal Study. A total of 2856 older adults with complete data in the 2011, 2013, and 2015 waves were included in our study. Participants were categorized into 3 states: no sarcopenia, possible sarcopenia, and sarcopenia according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Continuous-time multistate Markov model was performed to estimate the 1-year transition probabilities and the associated factors of sarcopenia transitions. The association strength was expressed as hazard ratio and 95% confidence interval. Results: The progression and reversion rates between no sarcopenia and sarcopenia state were 6.01 and 9.20 per 100 person-years, respectively. The 1-year progression probability to possible sarcopenia was higher compared with the likelihood of moving to the sarcopenia state (0.127 vs 0.034). The reversion probability to no sarcopenia was also higher among those with possible sarcopenia (0.281 vs 0.157). Older age, rural living, worse cognition status, higher chronic disease numbers, and lower nutrition status measured by body mass index accelerated the sarcopenia progression. Cognition status and body mass index level were related to higher chances of reverting. Discussion and Implications: Possible sarcopenia might be a critical time window to promote sarcopenia reversion. Timely interventions aimed at delaying the progression and facilitating sarcopenia recovery should focus on improving cognitive function and nutrition levels.

Indexed as

Multistate Markov modelPossible sarcopeniaSarcopeniaTransitions

Identifiers

PMID37954524
PMCPMC10637947
OpenAlexW4386946672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.